Antigen receptors, including immunoglobulins and T-cell receptors, are known to be widely expressed by cancer cells through unconfirmed mechanisms and for unknown purposes. Recently, a monoclonal antibody, designated as RP215, was generated against the ovarian cancer cell line, OC-3-VGH, and was shown to react with CA215, which consisted mainly of these cancer cell-expressed antigen receptors. Experimental evidence has clearly indicated that cancerous immunoglobulins play significant roles in the growth and proliferation of cancer cells in vitro and in vivo . RP215 and anti-antigen receptor antibodies were equally effective in inducing apoptosis and complement-dependent cytotoxicity reactions to cultured cancer cells. Through gene regulation studies, both RP215 and antibodies against antigen-receptors were shown to affect more than a dozen of genes involved in cell proliferation (such as NFκB-1, IgG, P21, cyclin D1, ribosomal P 1 , and c-fos) . Furthermore, selected toll-like receptor genes (TLR- 2, -3, -4, and -9) were also found to be highly regulated by both RP215 and anti-antigen receptor antibodies. For example, RP215 and anti-antigen receptor antibodies were found to both up-regulate TLR-2 and/or TLR-3 and down- regulate TLR-4 and TLR-9 intwo types of cancer cells. Based on these studies, it is reasonable to postulate that cancerous immunoglobulins play important roles in the modulation of the innate immune system to allow the growth and survival of cancer cells within the human body. Consequently, RP215 inits humanized forms may be utilized to target cancer cells for potential therapeutic purposes .
Kimoto, Y. (1998) Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines. Genes, Chromosomes and Cancer, 22, 83-86. doi:10.1002/(SICI)1098-2264(1998)22:1 3.0.CO;2-O
Li, J., Tan, C., Xiang, Q., Zhang, X., Ma, J., Wang, J.-R., et al. (2001) Proteomic detection of changes in protein synthesis induced by NGX6 transfected in human nasopharyngeal carcinoma cells. Journal of Protein Chemistry, 20, 265-271. doi:10.1023/A:1010912311564
Qiu, X., Zhu, X., Zhang, L., Mao, Y., Zhang, J., Hao, P., et al. (2003) Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Research, 63, 6488- 6495. http://cancerres.aacrjournals.org/content/63/19/6488.abstract
Li, M., Feng, D.-Y., Ren, W., Zheng, L., Zheng, H., Tang, M., et al. (2004) Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. International Journal of Biochemistry and Cell Biology, 36, 2250-2257. doi:10.1016/j.biocel.2004.03.017
Babbage, G., Ottensmeier, C., Blaydes, J., Stevenson, F., and Sahota, S. (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Research, 66, 3996-4000. doi:10.1158/0008-5472.CAN-05-3704
Chen, Z. and Gu, J. (2007) Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB Journal, 21, 2931-2938. doi:10.1096/fj.07-8073com
Zheng, H., Li, M., Liu, H., Ren, W., Hu, D.-S., Shi, Y., et al. (2007) Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biology International, 31, 82-87. doi:10.1016/j.cellbi.2006.09.009
Zheng, H., Li, M., Ren, W., Zeng, L., Liu, H.-D., Hu, D., et al. (2007) Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Molecular Immunology, 44, 2221-2227. doi:10.1016/j.molimm.2006.11.010
Huang, J., Sun, X., Mao, Y., Zhu, X., Zhang, P., Zhang, L., et al. (2008) Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons. International Journal of Biochemistry and Cell Biology, 40, 1604-1615. doi:10.1016/j.biocel.2007.12.004
Lee, G., Laflamme, E., Chien, C.-H. and Ting, H.H. (2008) Molecular identity of a pan cancer marker, CA215. Cancer Biology and Therapy, 7, 2007-2014. doi:10.4161/cbt.7.12.6984
Zhu, X., Li, C., Sun, X., Mao, Y., Li, G., Liu, X., et al. (2008) Immunoglobulin mRNA and protein expression in human oral epithelial tumor cells. Applied Immunohistochemistry & Molecular Morphology, 16, 232-238. doi:10.1097/PAI.0b013e31814c915a
Huang, J., Zhang, L., Ma, T., Zhang, P. and Qiu, X. (2009) Expression of immunoglobulin gene with classical V-(D)- J rearrangement in mouse testis and epididymis. Journal of Histochemistry and Cytochemistry, 57, 339-349. doi:10.1369/jhc.2008.951434
Lee, G. and Ge, B. (2009) Cancer cell expressions of immunoglobulin heavy chains with unique carbohydrate-associated biomarker. Cancer Biomarkers, 5, 177-188.
Zheng, J., Huang, J., Mao, Y., Liu, S., Sun, X., Zhu, X., et al. (2009) Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells. Journal of Biological Chemistry, 284, 13610- 13619. doi:10.1074/jbc.M809524200
Zhang, S., Mao, Y., Huang, J., Ma, T., Zhang, L., Zhu, X., et al. (2010) Immunoglobulin gene locus events in epithelial cells of lactating mouse mammary glands. Cellular and Molecular Life Sciences, 67, 985-994. doi:10.1007/s00018-009-0231-z
Hu, D., Duan, Z., Li, M., Jiang, Y., Liu, H., Zheng, H., et al. (2011) Heterogeneity of aberrant immunoglobulin expression in cancer cells. Cellular and Molecular Immunology, 8, 479-485. doi:10.1038/cmi.2011.25
Zhang, L., Hu, S., Korteweg, C., Chen, Z., Qiu, Y., Su, M., et al. (2012) Expression of immunoglobulin G in esophageal squamous cell carcinomas and its association with tumor grade and Ki67. Human Pathology, 43, 423- 434. doi:10.1016/j.humpath.2011.05.020
Hu, F., Zhang, L., Zheng, J., Zhao, L., Huang, J., Shao, W., et al. (2012) Spontaneous production of immunoglobulin M in human epithelial cancer cells. PLoS ONE, 7, e51423. doi:10.1371/journal.pone.0051423
Li, M., Zheng, H., Duan, Z., Liu, H., Hu, D., Bode, A., et al. (2012) Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines. Cellular & Molecular Immunology, 9, 54-61. doi:10.1038/cmi.2011.40
Lee, C.Y., Chen, K.W., Sheu, F.S., Tsang, A., Chao, K.C., and Ng, H.T. (1992) Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody. Cancer Immunology, Immunotherapy, 35, 19-26. doi:10.1007/BF01741050
Lee, G., Wu, Q., Li, C. H., Ting, H.H. and Chien, C.-H. (2006) Recent studies of a new carbohydrate-associated pan cancer marker, CA215. Journal of Clinical Ligand Assay, 29, 47-51. doi:10.4161/cbt.7.12.6984
Lee, G., Zhu, M., Ge, B. and Potzold, S. (2012) Widespread expressions of immunoglobulin superfamily proteins in cancer cells. Cancer Immunology, Immunotherapy, 61, 89-99. doi:10.1007/s00262-011-1088-1
Lee, G. and Azadi P. (2012) Peptide mapping and glycoanalysis of cancer cell-expressed glycoproteins CA215 recognized by RP215 monoclonal antibody. Journal of Carbohydrate Chemistry, 31, 10-30. doi:10.1080/07328303.2011.626544
Lee, G., Ge, B., Huang, T.-K., Zheng, G., Duan, J. and Wang, I.H.Y. (2009) Positive identification of CA215 pan cancer biomarker from serum specimens of cancer patients. Cancer Biomarkers, 6, 111-117.
Lee, G., Zhu, M., Ge, B., Cheung, A. P., Chien, C.-H., Chow, S.-N., et al. (2012) Carbohydrate-associated immunodominant epitope(s) of CA215. Immunological Investigations, 41, 317-336. doi:10.3109/08820139.2011.633141
Qiu, X., Liu, W. and Lee, G. (2013) The application of RP215 monoclonal antibody in the study of proliferation, migration, chemo-resistance, of cancer cells as well as cancer stem cells. Chinese Patent No. 201110211923.8.
Lee, G., Cheung, A., Ge, B., Zhu, M., Giolma, B., Li, B., et al. (2012) CA215 and GnRH receptor as targets for cancer therapy. Cancer Immunology, Immunotherapy, 1- 13. doi:10.1007/s00262-012-1230-8
Tang, Y., Zhang, H. and Lee, G. (2013) Similar gene regulation patterns for growth inhibition of cancer cells by RP215 or anti-antigen receptors. Journal of Cancer Science and Therapy, 5, 200-208. doi:10.4172/1948-5956.1000207
So, E.Y. and Ouchi, T. (2010) The application of toll like receptors for cancer therapy. International Journal of Biological Sciences, 6, 675-681. doi:10.7150/ijbs.6.675
Hu, D., Zheng, H., Liu, H., Li, M., Ren, W., Liao, W., et al. (2008) Immunoglobulin expression and its biological significance in cancer cells. Cellular and Molecular Immunology, 5, 319-324. doi:10.1038/cmi.2008.39
Chen, Z., Qiu, X. and Gu, J. (2009) Immunoglobulin expression in non-lymphoid lineage and neoplastic cells. American Journal of Pathology, 174, 1139-1148. doi:10.2353/ajpath.2009.080879
Lee, G. (2012) Cancerous immunoglobulins and CA215: Implications in cancer immunology. American Journal of Immunology, 8, 101-116. http://0.3844/ajisp.2012.101.116
Chen, Z., Huang, X., Ye, J., Pan, P., Cao, Q., Yang, B., et al. (2010) Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer, 116, 1953-1963. doi:10.1002/cncr.24892
Liu, Y., Chen, Z., Niu, N., Chang, Q., Deng, R., Korteweg, C., et al. (2012) IgG gene expression and its possible significance in prostate cancers. The Prostate, 72, 690-701. doi:10.1002/pros.21476
Niu, N., Zhang, J., Guo, Y., Zhao, Y., Korteweg, C. and Gu, J. (2011) Expression and distribution of immunoglobulin G and its receptors in the human nervous system. International Journal of Biochemistry and Cell Biology, 43, 556-563. doi:10.1016/j.biocel.2010.12.012
Niu, N., Zhang, J., Huang, T., Sun, Y., Chen, Z., Yi, W., et al. (2012) IgG expression in human colorectal cancer and its relationship to cancer cell behaviors. PLoS One, 7, e47362. doi:10.1371%2Fjournal.pone.0047362
Niu, N., Zhang, J., Wang, S., Sun, Y., Korteweg, C., Gao, W., et al. (2011) Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: The eye. Cellular and Molecular Life Sciences, 68, 2481-2492. doi:10.1007/s00018-010-0572-7
Qiu, Y., Korteweg, C., Chen, Z., Li, J., Luo, J., Huang, G., et al. (2012) Immunoglobulin G expression and its colocalization with complement proteins in papillary thyroid cancer. Modern Pathology, 25, 36-45. doi:10.1038/modpathol.2011.139
Zhao, Y., Liu, Y., Chen, Z., Korteweg, C. and Gu, J. (2011) Immunoglobulin G (IgG) expression in human umbilical cord endothelial cells. Journal of Histochemistry and Cytochemistry, 59, 474-488. http://jhc.sagepub.com/content/59/5/474.abstract
Zhu, X., Wu, L., Zhang, L., Hao, P., Zhang, S., Huang, J., et al. (2010) Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells. Cellular Molecular Immunology, 7, 279-286. doi:10.1038/cmi.2010.13
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T. (2000) Class switch recombinetion and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 102, 553-563. doi:10.1016/S0092-8674(00)00078-7
Papavasiliou, F.N. and Schatz, D.G. (2002) Somatic hypermutation of immunoglobulin genes: Merging mechanisms for genetic diversity. Cell, 109, S35-S44. doi:10.1016/S0092-8674(02)00706-7
Honjo, T., Kinoshita, K. and Muramatsu M. (2002) Molecular mechanism of class switch recombination: Linkage with somatic hypermutation. Annual Review of Immunology, 20, 165-196. doi:10.1146/annurev.immunol.20.090501.112049
Lee, G., Cheung, A.P., Li, B., Ge, B. and Chow, P.-M. (2012) Molecular and immuno-characteristics of immunoglobulin-like glycoproteins in cancer cell-expressed biomarker, CA215. Immunological Investigations, 41, 429-446. doi:10.3109/08820139.2012.661007
Chu, P.G. and Weiss, L.M. (2002) Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohisto- chemical study of 509 cases. Modern Pathology, 15, 6-10. doi:10.1038/modpathol.3880483
Lee, G., Zhu, M. and Ge, B. (2012) Potential monoclonal antibody therapy for the treatment of ovarian cancer. In: Farghaly, S.A., Ed., Ovarian Cancer-Basic Science Perspective, InTech, Vancouver, 385-406. doi:10.5772/27471
Lee, G. and Ge, B. (2010) Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies. Cancer Immunology, Immunotherapy, 59, 1347-1356. doi:10.1007/s00262-010-0864-7
Koropatnick, T.A., Engle, J.T., Apicella, M.A., Stabb, E.V., Goldman, W.E. and McFall-Ngai, M.J. (2004) Microbial factor-mediated development in a host-bacterial mutualism. Science, 306, 1186-1188. doi:10.1126/science.1102218
O’Neill, L.A., Bryant, C.E. and Doyle, S.L. (2009) Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacological Reviews, 61, 177-197. doi:10.1124/pr.109.001073
Rakoff-Nahoum, S. and Medzhitov, R. (2009) Toll-like receptors and cancer. Nature Reviews. Cancer, 9, 57-63.
Cook, D.N., Pisetsky, D.S. and Schwartz, D.A. (2004) Toll-like receptors in the pathogenesis of human disease. Nature Immunology, 5, 975-979.
Morikawa, T., Sugiyama, A., Kume, H., Ota, S., Kashima, T., Tomita, K., et al. (2007) Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clinical Cancer Research, 13, 5703-5709. doi:10.1158/1078-0432.CCR-07-0603
Salaun, B., Lebecque, S., Matikainen, S., Rimoldi, D. and Romero, P. (2007) Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clinical Cancer Research, 13, 4565-4574. doi:10.1158/1078-0432.CCR-07-0274
Yang, H., Zhou, H., Feng, P., Zhou, X., Wen, H., Xie, X., et al. (2010) Reduced expression of toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. Journal of Experimental and Clinical Cancer Research, 29, 92. doi:10.1186/1756-9966-29-92
Droemann, D., Albrecht, D., Gerdes, J., Ulmer, A.J., Branscheid, D., Vollmer, E., et al. (2005) Human lung cancer cells express functionally active toll-like receptor 9. Respiratory Research, 6, 1. doi:10.1186/1465-9921-6-1
Ilvesaro, J.M., Merrell, M.A., Swain, T.M., Davidson, J., Zayzafoon, M., Harris, K.W., et al. (2007) Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate, 67, 774-781. doi:10.1002/pros.20562
Merrell, M.A., Ilvesaro, J.M., Lehtonen, N., Sorsa, T., Gehrs, B., Rosenthal, E., et al. (2006) Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Molecular Cancer Research, 4, 437-447. doi:10.1158/1541-7786.MCR-06-0007
Salaun, B., Coste, I., Rissoan, M.C., Lebecque, S.J. and Renno, T. (2006) TLR3 can directly trigger apoptosis in human cancer cells. Journal of Immunology, 176, 4894- 4901. http://www.jimmunol.org/content/176/8/4894
O’Sullivan, T., Saddawi-Konefka, R., Vermi, W., Koebel, C.M., Arthur, C., White, J.M., et al. (2012) Cancer immunoediting by the innate immune system in the absence of adaptive immunity. The Journal of Experimental Medicine, 209, 1869-1882. doi:10.1084%2Fjem.20112738
Sato, Y., Goto, Y., Narita, N. and Hoon, D.S. (2009) Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenvironment, 2, 205-214. doi:10.1007%2Fs12307-009-0022-y
Lee, J.W., Choi, J.J., Seo, E.S., Kim, M.J., Kim, W.Y., Choi, C.H., et al. (2007) Increased toll-like receptor 9 expression in cervical neoplasia. Molecular Carcinogenesis, 46, 941-947.
Kelly, M.G., Alvero, A.B., Chen, R., Silasi, D.-A., Abrahams, V.M., Chan, S., et al. (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Research, 66, 3859-3868. doi:10.1158/0008-5472.CAN-05-3948
Nishimura, M. and Naito, S. (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biological and Pharmaceutical Bulletin, 28, 886-892. doi:10.1248/bpb.28.886
Kim, W.Y., Lee, J.W., Choi, J.J., Choi, C.H., Kim, T.J., Kim, B.G., et al. (2008) Increased expression of toll-like receptor 5 during progression of cervical neoplasia. International Journal of Gynecological Cancer, 18, 300- 305. doi:10.1111/j.1525-1438.2007.01008.x
Huang, B., Zhao, J., Li, H., He, K.L., Chen, Y., Chen, S.H., et al. (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Research, 65, 5009-5014. doi:10.1158/0008-5472.CAN-05-0784
Zhou, M., McFarland-Mancini, M.M., Funk, H.M., Husseinzadeh, N., Mounajjed, T. and Drew, A.F. (2009) Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunology, Immunotherapy, 58, 1375- 1385. doi:10.1007/s00262-008-0650-y
Li, Q., Withoff, S. and Verma, I.M. (2005) Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends in Immunology, 26, 318-325. doi:10.1016/j.it.2005.04.003
Griffin, J.D. (2001) Leukemia stem cells and constitutive activation of NF-kappaB. Blood, 98, 2291. doi:10.1182/blood.V98.8.2291a
Xie, W., Wang, Y., Huang, Y., Yang, H., Wang, J. and Hu, Z. (2009) Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells. Biochemical and Biophysical Research Communications, 379, 1027-1032. doi:10.1016/j.bbrc.2009.01.009
Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461-466.
So, E.Y. and Ouchi, T. (2010) The application of toll like receptors for cancer therapy. International Journal of Biological Sciences, 6, 675-681. doi:10.7150/ijbs.6.675
Vesely, M.D., Kershaw, M.H., Schreiber, R.D. and Smyth, M.J. (2011) Natural innate and adaptive immunity to cancer. Annual Review of Immunology, 29, 235-271. doi:10.1146/annurev-immunol-031210-101324
Schmausser, B., Andrulis, M., Endrich, S., Muller-Hermelink, H.K. and Eck, M. (2005) Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: An implication for interaction with Helicobacter pylori. International Journal of Medical Microbiology, 295, 179- 185. doi:10.1016/j.ijmm.2005.02.009
Furrie, E., Macfarlane, S., Thomson, G. and Macfarlane, G.T. (2005) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology, 115, 565-574. doi:10.1111%2Fj.1365-2567.2005.02200.x
Huang, B., Zhao, J., Unkeless, J.C., Feng, Z.H. and Xiong, H. (2008) TLR signaling by tumor and immune cells: A double-edged sword. Oncogene, 27, 218-224. doi:10.1038/sj.onc.1210904
O’Neill, L.A. (2004) TLRs: Professor Mechnikov, sit on your hat. Trends in Immunology, 25, 687-693. doi:10.1016/j.it.2004.10.005.